Achieve a sustainable supplier strategy with the internationally recognised FSC product range from Fasson. Recognised by the World Wildlife Fund and Greenpeace, Fasson FSC paper products will help you fully meet the exacting demands of leading international brands for a sustainable, eco-friendly future.
Beech Tree Labs, Inc., announced that the FDA has approved its IND for a Phase 1/2a clinical evaluation of BTL-TML-HSV, a novel therapeutic agent for treating recurrent oral herpes infections. The study will be a 210 patient, multi-site, placebo-controlled trial and is anticipated to begin later this summer.
Daiichi Sankyo has signed a research and commercial agreement with BioWa, Inc. and Lonza to use their POTELLIGENT® CHOK1SV cell line for the development and production of recombinant antibodies.
The top results of FPS Food and Pharma Systems' Srl research is the worldwide smallest jet mill for early R&D needs.
Multipharma is committed to offering its clients the highest quality standards available and therefore has chosen Movianto as its preferred logistics provider to cope with the increasing demand for the supply of non-IMP's to study sites.
Elusys Therapeutics and Lonza today announced an agreement for the scale-up and commercial production of Anthim®, a therapeutic monoclonal antibody in late-stage development for the treatment of inhaled anthrax. Under the new contract, Lonza will provide process scale-up, technology transfer, validation, and commercial manufacturing at one of its facilities in the US. The manufacturing process for Anthim was optimised for full-scale production by Lonza under a separate agreement announced in June 2009. The Anthim manufacturing process uses Lonza’s GS Gene Expression System™.
Innovaro, a comprehensive innovation solutions company, today announced they have signed an ongoing IP services agreement with Core Oncology, Inc., an innovator in the field of radiation oncology, introduced by Verdant Ventures Advisors LLC.
Accuri Cytometers, Inc., a world leader in providing life science researchers with easy-to-use, cost-effective flow cytometers, today announced completion of a $6 million Series E preferred stock financing
Penn Pharma and Xcelience, LLC today announced that the two companies have entered into a joint venture agreement to provide Capsugel's Xcelodose® precision powder micro-dosing system technology on a global basis.
The book Cancer Risk Assessment (John Wiley & Sons) is now available. The book provides a comprehensive overview of key fundamentals in cancer biology, cancer risk assessment, science policy, testing guidelines, regulatory frameworks, and methods needed to perform cancer risk assessments.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.